Frequency and safety of pegfilgrastim use in patients with lung cancer treated with combination therapy of cytotoxic chemotherapy and immune checkpoint inhibitors: A CS-lung-003-registry-based prospective observational study

JAAD International · Elsevier

Аннотация

Publication date: December 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 4 Author(s): Tomoki Tamura, Kazuya Nishii, Yukari Tsubata, Naoki Watanabe, Masahiro Kodani, Takeshi Masuda, Masaaki Inoue, Masahiro Yamasaki, Nobuaki Ochi, Tetsuya Kubota, Hirohisa Ichikawa, Nobuhisa Ishikawa, Shingo Harita, Nobukazu Fujimoto, Ichiro Takata, Soichi Kitaguchi, Tatsuya Nishi, Naoki Nakamura, Katsuyuki Hotta, Katsuyuki Kiura

Читать у издателя →

Похожие статьи